Lv1
34 积分 2021-10-04 加入
VEGF signaling: Role in angiogenesis and beyond
1个月前
已完结
The landscape of cancer research and cancer care in China
1个月前
已完结
Outcomes of Relapsed or Refractory Diffuse Large B‐Cell Lymphoma Treated With R‐GemOx: A Multicenter Cohort Study
1个月前
已完结
Ivonescimab versus pembrolizumab for PD-L1-positive non-small cell lung cancer (HARMONi-2): a randomised, double-blind, phase 3 study in China
1个月前
已完结
TGF-β mediated drug resistance in solid cancer
1个月前
已完结
TGF-β-driven EMT in cancer progression and drug resistance
1个月前
已完结
Enhancing cancer immunotherapy using antiangiogenics: opportunities and challenges
1个月前
已完结
Nivolumab plus ipilimumab combination therapy in cancer: Current evidence to date
1个月前
已完结
Nivolumab plus ipilimumab versus nivolumab in microsatellite instability-high metastatic colorectal cancer (CheckMate 8HW): a randomised, open-label, phase 3 trial
1个月前
已完结
皖公网安备34019202002308
